RESEARCH EDUCATION CORE ABSTRACT: The CDU/UCLA Cancer Center Partnership's Research Education Core is central component to provide and facilitate research educational experiences for undergraduate, graduate, medical, post-doctoral, medical residents, clinical fellows, and early stage investigators (ESIs) to conduct translational cancer health disparities research. In addition, this Research Education Core will continue to play a critical role in providing research instruction to community partners in partnership with our community outreach core and health service providers that include: community oncologists, primary care physicians and internists engaged in our Clinical Resource Service Core. The Research Education Core will serve as portals to the other cores to enhance cancer education, care, treatment and prevention. The Research Education Core will provde interactive and integrated approaches for interdisciplinary and transdisciplinary programs and activities for reducing cancer health disparities. The Core will provide four unique research experience programs: 1) a short-term 8-12 week summer intensive research experience for undergraduate-level students in basic, clinical, or community-based science, 2) research internships for graduate and medical students and for post-doctoral and ESIs, 3) long- term research experiences for post-doctoral and ESIs, and 4) a community/academic research experience for community faculty. Student scholars will be placed either at CDU or UCLA with mentors who have experience in cancer health disparities and the student's research interest. The mentor will guide them on a hypothesis- driven project. In addition to hands-on experience, scholars are required to participate in both scientific and career-development seminars and workshops, research-in-progress presentations, professional presentations, manuscript development, and grant proposal development (for graduate to ESIs). The Core has developed an Internal Mentoring Committee composed of CDU and UCLA PIs and IAC members to review the individualized outcomes of scholars, particularly ESIs. Evaluation and Tracking outcomes will be regularly reported and discussed as part of the Planning and Evaluation Core activities. The overarching goal is to develop a diverse cadre of scholars, through hands-on research experiences, into tomorrow's leaders who address will the social, community-based, and biomedical challenges which contribute to cancer disparities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54CA143931-06
Application #
9037354
Study Section
Special Emphasis Panel (ZCA1-PCRB-C (O1))
Project Start
2009-09-29
Project End
2020-08-31
Budget Start
2015-09-25
Budget End
2016-08-31
Support Year
6
Fiscal Year
2015
Total Cost
$230,844
Indirect Cost
$69,977
Name
Charles R. Drew University of Medicine & Science
Department
Type
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Boonyaratanakornkit, Viroj; Hamilton, Nalo; Márquez-Garbán, Diana C et al. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol 466:51-72
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Maxwell, Annette E; Young, Sandra; Moe, Emily et al. (2018) Understanding Factors that Influence Health Care Utilization Among Mixtec and Zapotec Women in a Farmworker Community in California. J Community Health 43:356-365
Maxwell, Annette E; Castillo, Laura; Arce, Anthony A et al. (2018) Eating Veggies Is Fun! An Implementation Pilot Study in Partnership With a YMCA in South Los Angeles. Prev Chronic Dis 15:E132
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Hamilton, Nalo; Austin, David; Márquez-Garbán, Diana et al. (2017) Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci 18:
La, V; Fujikawa, R; Janzen, D M et al. (2017) Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy. NPJ Precis Oncol 1:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Wu, Yong; Yu, Xiaoting; Yi, Xianghua et al. (2017) Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res 77:1383-1394
Wang, Piwen; Solorzano, Walter; Diaz, Tanya et al. (2017) Arctigenin inhibits prostate tumor cell growth in vitro and in vivo. Clin Nutr Exp 13:1-11

Showing the most recent 10 out of 90 publications